Breakthrough in fight against Hendra virus

Oct 30, 2009
Breakthrough in fight against Hendra virus
An artificially coloured transmission electron micrograph of Hendra virus. (CSIRO)

(PhysOrg.com) -- There has been a breakthrough in the fight against the deadly Hendra virus following the development of a treatment which shows great potential to save the lives of people who become infected with the virus.

A scientific team from CSIRO and the US has demonstrated that administering human monoclonal after exposure to Nipah virus, which is closely related to Hendra virus, protected animals from challenge in a disease model.

According to CSIRO's Dr Deborah Middleton, who led the experiments at Australia's maximum biosecurity facility, CSIRO's Australian Animal Health Laboratory (AAHL) in Geelong, said the findings are extremely encouraging.

"Our research clearly suggests that an effective treatment for Hendra virus infections in humans should be possible, given the very strong cross-reactive activity this antibody has against ," she said.

Antibodies - proteins found in blood or other bodily fluids of vertebrates - are used by the immune system to identify and neutralise bacteria and viruses.

First identified in Brisbane and isolated by CSIRO scientists in 1994, Hendra , which spreads from flying foxes, has regularly infected horses in Australia. Of the 12 equine outbreaks, four have led to human infection, with four of the seven known human cases being fatal, the most recent of these in September 2009. Human infection results from close contact with the blood and/or mucus of infected horses.

Dr Middleton said the success of the antibody will probably depend on dose and time of administration.

"As Hendra and Nipah viruses cause severe disease in humans, a successful application of this antibody as a post-exposure therapy will likely require early intervention.

"To make clinical use of it against these viruses, it will need to be prepared under proper manufacturing guidelines, carefully evaluated again in animal models and safety tested for human use. We hope this demonstration of antiviral activity will lead to some immediate activities to facilitate further development for its use in humans," Dr Middleton said.

The results of this latest research, conducted in collaboration with scientists from the US's Uniformed Services University of the Health Sciences, National Cancer Institute and the National Institutes of Health in the US, were published today in the journal PLoS Pathogens.

More information: dx.plos.org/10.1371/journal.ppat.1000642

Provided by CSIRO (news : web)

Explore further: Top Japan lab dismisses ground-breaking stem cell study

add to favorites email to friend print save as pdf

Related Stories

Minimising the spread of deadly Hendra virus

Mar 31, 2009

(PhysOrg.com) -- CSIRO Livestock Industries' scientists working at the Australian Animal Health Laboratory (AAHL), in Geelong Victoria, have made a major breakthrough in better understanding how Hendra spreads ...

Scientists Develop Vaccine Against Deadly Viruses

Oct 04, 2006

Scientists from the Uniformed Services University of the Health Sciences (USU), in collaboration with counterparts from the Australian Animal Health Laboratory (AAHL), have developed a vaccine to fight two deadly animal viruses ...

Discovery could be key to bioterrorism defense

Jul 30, 2005

A collaborative research team from the Uniformed Services University of the Health Sciences (USU), the Australian Animal Health Laboratory (AAHL) and the National Cancer Institute (NCI) have made a major breakthrough in efforts ...

Drug blocks two of world's deadliest emerging viruses

Mar 05, 2009

Two highly lethal viruses that have emerged in recent outbreaks are susceptible to chloroquine, an established drug used to prevent and treat malaria, according to a new basic science study by researchers at Weill Cornell ...

New reovirus isolated

Jun 27, 2007

CSIRO scientists have played a key role in discovering that bats are the likely host of a new virus that can cause a serious but apparently non-fatal respiratory tract illness in humans.

Recommended for you

Top Japan lab dismisses ground-breaking stem cell study

Dec 26, 2014

Japan's top research institute on Friday hammered the final nail in the coffin of what was once billed as a ground-breaking stem cell study, dismissing it as flawed and saying the work could have been fabricated.

Research sheds light on what causes cells to divide

Dec 24, 2014

When a rapidly-growing cell divides into two smaller cells, what triggers the split? Is it the size the growing cell eventually reaches? Or is the real trigger the time period over which the cell keeps growing ...

Locking mechanism found for 'scissors' that cut DNA

Dec 24, 2014

Researchers at Johns Hopkins have discovered what keeps an enzyme from becoming overzealous in its clipping of DNA. Since controlled clipping is required for the production of specialized immune system proteins, ...

Scrapie could breach the species barrier

Dec 24, 2014

INRA scientists have shown for the first time that the pathogens responsible for scrapie in small ruminants (prions) have the potential to convert the human prion protein from a healthy state to a pathological ...

Extracting bioactive compounds from marine microalgae

Dec 24, 2014

Microalgae can produce high value health compounds like omega-3s , traditionally sourced from fish. With declining fish stocks, an alternative source is imperative. Published in the Pertanika Journal of Tr ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.